Hypezil 5 mg (Donepezil Hydrochloride Hydrate), Hypezil 10 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 10.44mg
Prescription medication
Hyundai Pharmaceutical Co., Ltd.
MFDS item code 202201524 · Approved 2022.04.11 · Insurance code 642004851,642004861
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms of Alzheimer's disease. It helps relieve dementia symptoms such as memory decline and cognitive dysfunction, thereby improving the patient's daily life.
○ Adults: Administer 1 sachet once daily (containing 5 mg of donepezil hydrochloride) at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose increase, administer 1 sachet (containing 5 mg of donepezil hydrochloride) for 4-6 weeks. After assessing the clinical response during this period, the dose may be increased to 1 sachet (containing 10 mg of donepezil hydrochloride). When increasing the dose to 1 sachet daily (containing 10 mg of donepezil hydrochloride), administer with caution for gastrointestinal adverse reactions. When treatment with this medicine is stopped, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Women aged 85 years and older with low body weight: Close monitoring is necessary because adverse reactions occur more frequently. Older women with low body weight should not exceed 1 sachet daily (containing 5 mg of donepezil hydrochloride). ○ Take this medicine with water and do not divide the contents of a sachet.
○ Children: There is no experience with use in children.
This medication contains donepezil hydrochloride as the active ingredient and is used to treat Alzheimer's disease. It should not be used in patients who are allergic to donepezil hydrochloride, piperidine derivatives, or any of the other components of this medication. It is recommended that women who are pregnant or may become pregnant, as well as breastfeeding women, do not take this medication. This medication contains lactose, so patients with hereditary diseases such as galactose intolerance, LAPP lactose deficiency, or glucose-galactose malabsorption should not take it. Patients with heart disease or those with bradycardia syndrome, atrial and ventricular conduction block should be cautious as this medication may stimulate the vagus nerve and potentially cause bradycardia or arrhythmia. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should use this medication cautiously, as it may increase gastric secretion and gastrointestinal motility, worsening ulcers. Those with a history of asthma or obstructive pulmonary disease should be cautious as symptoms may worsen due to bronchoconstriction and increased mucus secretion. Patients with extrapyramidal disorders such as Parkinson's disease should take this medication with caution due to the potential for worsening symptoms. Severe side effects such as fainting, bradycardia, heart block, gastrointestinal bleeding, liver dysfunction, vascular abnormalities, and muscle cramps may occur during treatment. If any unusual symptoms appear, consult a doctor immediately. Common side effects can also include nausea, vomiting, diarrhea, dizziness, insomnia, headache, fatigue, and more. Patients with heart disease or a history of QT interval prolongation may require electrocardiogram monitoring due to the risk of arrhythmias. This medication is metabolized by the CYP3A4 and CYP2D6 enzymes, hence caution should be taken when used with medications that inhibit or induce these enzymes, as they may alter drug effectiveness. Additionally, combining this medication with other cholinergic or anticholinergic drugs may lead to interactions, so inform your doctor or pharmacist. Be cautious while driving or operating machinery, as dizziness or drowsiness may occur, especially during the initial treatment or when changing dosages. It is advisable not to use this medication during pregnancy, and if breastfeeding, it is safer to stop breastfeeding or avoid taking it. Safety in pediatric patients has not been established, so it is not used in this group. In case of overdose, severe symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, requiring immediate medical attention. Atropine may be used as an antidote. This medication should not be divided when taking one sachet and should be stored out of reach of children. Also, transferring the medication to another container may lead to a deterioration in quality or accidents, so be cautious.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that can block light, at a temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication over time.
This medication is a white powder.
30 sachets/box [0.5 g/sachet x 30], 30 sachets/box [1 g/sachet x 30]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 10.44mg
Prescription medication
Hyundai Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.